suspicion of prostate cancer prostate cancer, biopsy, MRI
Conditions
Interventions
Sponsors
Akamatsu Shusuke
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients that fulfill criteria I and either II or III who are eligible for prostatectomy and can give consent to the study. I. Serum PSA elevation (>=2.5ng/ml, =20, <90
Exclusion criteria
Exclusion criteria: Either of the below. I. patients who would not benefit from diagnoses of prostate cancer II. patients with PSA >=20ng/ml, who are likely to have advanced prostate cancer III. suspicious of advanced prostate cancer by digital rectal exam IV. suspicious of advanced prostate cancer by MRI V. patients who cannot undergo prostate biopsy due to coagulation disorders VI. patients who are not eligible for spinal, sacral, or general anesthesia due to allergy VII. patients who are not eligible for the study determined by the treating physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a) Positive prostate cancer rate by biopsy b) Comparison of 3D cancer localization at prostate needle biopsy and the actual localization in prostatectomy specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of adverse events using historical control. (specific adverse events of prostate needle biopsy are 1. pain, 2. bleeding, 3. infection, 4. hematuria, 5. fever) | — |
Contacts
Public ContactShusuke Akamatsu
Kyoto University Hospital
Outcome results
None listed